Originally posted by Tim
View Post
Disclaimer: I have no medical or scientific knowledge, but may have half a clue when reading and comprehending the NEJM.
Pfizer while touting the recently published Israeli study on the effectiveness/protection their 2nd booster/4 dose against Omicron. While elsewhere suggesting a 5th or even 6th dose maybe necessary.
Maybe it is because in my reading of the study it is underwhelming. The increased effectiveness against infection starts diminishing after four (4) weeks and is mostly gone after eight (8).
While there is significant protection against severe illness, the study is really too short to give even near-term projections on half-life.
What a great product. The less effectiveness/protection it provides, the more doses are required and the more billion$ in profits.
Comment